nLife Therapeutics' Series B Round

nLife Therapeutics raised a round of funding on June 20, 2014.

nLife Therapeutics develops treatments for CNS diseases and is working on next generation targeted nucleic acids products. The company's technology delivers conjugated nucleic acids with small chemica…

Articles about nLife Therapeutics' Series B Round: